Who are Vaxcyte's investors?

Vaxcyte's investors include Frazier Healthcare, RA Capital Management, Janus Henderson Investors, Pivotal bioVenture Partners, TPG (Growth/Rise), Abingworth Bioventures.

Where is Vaxcyte headquartered?

Vaxcyte is headquartered in San Carlos, United States.

What industry is Vaxcyte in?

Vaxcyte operates in Biotech, Healthcare.

Vaxcyte

IPO

Homepage

Public · San Carlos, United States · Founded 2013

Biotech

Healthcare

Headquarters: San Carlos
Founded: 2013
Business Model: B2B
Website: vaxcyte.com

Last Round: Series DMar 2020
Rounds: 4
Type: Public

About

Vaxcyte is a clinical-stage vaccine innovation company headquartered in San Carlos, California, founded in 2013 by CEO Grant Pickering. The company re-engineers how complex vaccines are made using advanced chemistry and a proprietary cell-free protein synthesis platform to develop difficult-to-manufacture proteins with enhanced immunological benefits. Its pneumococcal conjugate vaccine franchise includes VAX-31 and VAX-24, in Phase 3 and Phase 2 clinical trials respectively, alongside early-stage programs targeting Group A Strep and Shigella.

Summary

Vaxcyte is a Biotech company based in San Carlos, United States, founded in 2013. Its most recent funding was a Series D round in Mar 2020. Investors include Frazier Healthcare, RA Capital Management and Janus Henderson Investors.